Bio Green Med Solution Inc Preferred Stock (BGMSP)

• Market cap: $420K
• 1 day: -1.9%
• 5 days: -2.21%
• 1 month: -15.99%
• 3 months: -25.3%
• 6 months: -35.42%
• Year to date: -14.13%
• 1 year: -60.41%
• 5 years: -58.39%
• 10 years: -45.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Bio Green Med Solution Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.

Employees: 12